12 Dec, 2022 Rebranding generics as branded medicines – CJEU issues new guidance By Heidi Hurdle The CJEU has provided welcome new guidance on when parallel importers are rebranding generics as branded medicines with the original...
23 Nov, 2022 To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines By Guillaume de Villegas Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its...